| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 01/09/2008 | EP1875903A1 Tuberculosis treatment using pleuromutilin derivatives |
| 01/09/2008 | EP1875900A2 JAK/STAT pathway inhibitors and the use thereof for the treatment of osteoarthritis |
| 01/09/2008 | EP1874356A2 Aminergic pharmaceutical compositions and methods |
| 01/09/2008 | EP1874355A2 Method of treatment using gh antagonist and somatostatin agonist |
| 01/09/2008 | EP1874354A1 Nutrient composition comprising green tea polyphenols for treating osteosarcoma |
| 01/09/2008 | EP1874353A1 Glutamate modulating agents in the treatment of mental disorders |
| 01/09/2008 | EP1874349A2 Use of cd25 antibodies in immunotherapy |
| 01/09/2008 | EP1874340A2 Elastin protective polyphenolics and methods of using the same |
| 01/09/2008 | EP1874316A1 Use of pde-5 inhibitors for endothelial repair of tissues impaired by trauma or disease |
| 01/09/2008 | EP1874286A2 Methods and compositions for the treatment of anxiety disorders |
| 01/09/2008 | EP1874285A2 Complementary compositions to reduce blood glucose levels and treat diabetes |
| 01/09/2008 | EP1651287B1 Injectable composite for the magnetocytolysis of bone metastatic cells |
| 01/09/2008 | EP1490053B1 Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and radiotherapy |
| 01/09/2008 | EP1411980B1 Uses of dc-sign and dc-signr for inhibiting hepatitis c virus infection |
| 01/09/2008 | EP1402890B1 Sulfonamide derivatives |
| 01/09/2008 | EP1283043B1 Ophthalmic solution |
| 01/09/2008 | EP1239877B1 Composition comprising a tnf-alpha inhibitor and an integrin alphavbeta3 receptor antagonist |
| 01/09/2008 | EP1115416B1 Use of substances with oxytocin activity in order to create cell regeneration |
| 01/09/2008 | EP0988042B1 Combination of product r and an antiviral agent in the therapy of hiv infections |
| 01/09/2008 | EP0970227B1 Recombinant antibodies and immunoconjugates targeted to cd-22 bearing cells and tumors |
| 01/09/2008 | EP0814789B2 Pharmaceutical compositions comprising monoamine oxidase b inhibitors |
| 01/09/2008 | CN101103013A 1-thio-D-glucitol derivatives |
| 01/09/2008 | CN101102795A Drug carrier and drug carrier kit for inhibiting fibrosis |
| 01/09/2008 | CN101102776A Antitumor agent |
| 01/09/2008 | CN101102760A Methods and reagents for the treatment of immunoinflammatory disorders |
| 01/09/2008 | CN101102757A Method for the treatment of polycystic kidney disease |
| 01/09/2008 | CN101099734A Agonism of the 5ht2a receptor for treatment of thermoregulatory dysfunction |
| 01/09/2008 | CN100360553C Compounds and use thereof to modify transport across cell membranes |
| 01/09/2008 | CN100360519C Benzothiepine ileal bile acid transport inhibitors |
| 01/09/2008 | CN100360185C Preparation method of medicine for treating pelada |
| 01/09/2008 | CN100360182C Induction of antigen specific immunologic tolerance |
| 01/09/2008 | CN100360174C Methods of treating disorders of the eye and surrounding tissue with thymosin beta4 (t beta 4), analogues, isoforms and other derivatives |
| 01/09/2008 | CN100360121C Methods and compositions for preventing and treating chronological aging in human skin |
| 01/08/2008 | USRE40000 Method of treatment for decreasing mortality resulting from congestive heart failure |
| 01/08/2008 | US7317107 Imidazole 4-carboxamide compounds with adenosine deaminase inhibiting activity |
| 01/08/2008 | US7317036 Prostaglandins for prostaglandin mediated diseases such as antihistamines |
| 01/08/2008 | US7317035 Tetracyclic arylcarbonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them |
| 01/08/2008 | US7317026 Sleep disorders; side effect reduction ; antihistamine antagonist |
| 01/08/2008 | US7317016 Methods of treating medical conditions using sulfonate-substituted pyrazolopyridine derivatives |
| 01/08/2008 | US7317011 Method of treating peripheral neuropathy |
| 01/08/2008 | US7317001 Inhibiting relapse of antibiotic-associated diarrhea in a patient by administering ramoplanin in an amount and for a duration effective to inhibit relapse of antibiotic associated diarrhea in the patient |
| 01/08/2008 | US7316927 Culture of goblet cells |
| 01/08/2008 | US7316913 Using microscopic systems to monitoring f-actin and myosin activity in cells; monitoring biopolymer transfer between membrane walls |
| 01/08/2008 | US7316818 Liposome drug delivery of polycyclic, aromatic, antioxidant or anti-inflammatory compounds |
| 01/08/2008 | US7316810 Foaming composition for washing and treating hair and/or scalp based on an active principle |
| 01/08/2008 | US7316657 Massage appliance with adjustable massage characteristics and storage container |
| 01/08/2008 | CA2347750C Pharmaceutical composition containing decursin |
| 01/08/2008 | CA2343713C Use of pex in the treatment of metabolic bone diseases |
| 01/08/2008 | CA2235375C Production of analgesic synergy by co-administration of sub-analgesic doses of a .mu. opioid agonist and a .kappa.-2 opioid agonist |
| 01/08/2008 | CA2181164C Anti-gram-positive bacterial methods and materials |
| 01/03/2008 | WO2008003013A2 Antitumorigenic drug combination comprising an hdac inhibitor and a tsp-1 peptidomimetic |
| 01/03/2008 | WO2008002905A2 Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same |
| 01/03/2008 | WO2008002539A1 Combinations comprising 5ht6 modulators and cholinesterase inhibitors |
| 01/03/2008 | WO2008001929A1 Treatment agent for inflammatory bowel disease |
| 01/03/2008 | WO2008001851A1 Drug, drug induction device, magnetic detector and method of designing drug |
| 01/03/2008 | WO2008001778A1 Genetically modified animal and use thereof |
| 01/03/2008 | WO2008001752A1 Treatment of chronic obstructive pulmonary disease by statin |
| 01/03/2008 | WO2008001499A1 Prophylactic and/or therapeutic agent for rheumatoid arthritis |
| 01/03/2008 | WO2008001184A2 Solid composition |
| 01/03/2008 | WO2008000731A2 Pharmaceutical composition for the oral administration of omega polyenoic fatty acids |
| 01/03/2008 | WO2008000513A2 Peptide compounds for the treatment of hyperexcitability disorders and diseases associated with ion channel dysfunction |
| 01/03/2008 | WO2008000137A1 Oral encapsulated preparation for aquatic animals, process for the preparation of same, and usage of same |
| 01/03/2008 | WO2007131182A3 System for high production of natural and personalized interferons |
| 01/03/2008 | WO2007126455A3 Method for using boc/cdo to modulate hedgehog signaling |
| 01/03/2008 | WO2007113243A3 Use of pde 5 inhibitors for the treatment of overactive bladder |
| 01/03/2008 | WO2005123131A3 High pressure spray-dry of bioactive materials |
| 01/03/2008 | WO2005021040A3 Compositions useful for treating gastrointestinal motility disorders |
| 01/03/2008 | WO2002053143A3 Treatment of erectile dysfunction with rho-kinase inhibitors |
| 01/03/2008 | US20080004450 cyclization; deprotecting; treatment of cancer and cancer which has developed multidrug-resistant phenotype |
| 01/03/2008 | US20080004331 for hepatitis C; histone deacetylase inhibitors; N-hydroxy-4-{[(naphthyl-carbonylamino]alkoxy}benzamides; anticarcinogenic agent; acute promyelocytic leukemia; cell-cycle arrest in late G1 phase or at the G2/M transition |
| 01/03/2008 | US20080004226 Combination of FBPase Inhibitors and Insulin Sensitizers for the Treatment of Diabetes |
| 01/03/2008 | US20080004225 New dialysis method |
| 01/03/2008 | US20080003675 Methods and compositions for identifying morphogen analogs |
| 01/03/2008 | US20080003304 Combination chemotherapy |
| 01/03/2008 | US20080003301 Copper lowering treatment of inflammatory and fibrotic diseases |
| 01/03/2008 | US20080003295 Bioadhesive nanoparticulate compositions having cationic surface stabilizers |
| 01/03/2008 | US20080003290 Phenethanolamine Derivatives for Treatment of Respiratory Diseases |
| 01/03/2008 | US20080003232 Cpg Single Strand Deoxynucleotides for Use as Adjuvant |
| 01/03/2008 | US20080003216 Administering an interleukin-18 binding protein (IL-18BP) for inhibiting melanoma cell liver and lung tissue metastasis; IL-18 (IFN gamma-inducing factor) |
| 01/03/2008 | US20080003199 IL-33 in the treatment and diagnosis of diseases and disorders |
| 01/03/2008 | US20080003179 Methods for measuring rates of reverse cholesterol transport in vivo, as an index of anti-atherogenesis |
| 01/03/2008 | DE102006030047A1 Topical product, useful e.g. for promoting symbiotic growth of Propionibacterium on e.g. skin and mucous membrane, comprises synthesis precursor for vitamin produced by Propionibacterium, antibacterial, antimycotic substance and/or sugar |
| 01/03/2008 | CA2655999A1 Treating agent of inflammatory bowel disease |
| 01/03/2008 | CA2655828A1 Compositions and methods of treating cns disorders |
| 01/03/2008 | CA2655615A1 A pharmaceutical composition for the oral administration of omega polyenoic fatty acids and one or more active principles incompatible therewith, and a process for its preparation |
| 01/03/2008 | CA2654986A1 Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same |
| 01/03/2008 | CA2654652A1 Peptide compounds for the treatment of hyperexcitability disorders and diseases associated with ion channel dysfunction |
| 01/02/2008 | EP1873259A1 RNA interference is mediated by 21 and 22nt small RNAs |
| 01/02/2008 | EP1873245A1 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 01/02/2008 | EP1872798A1 Intestinal absorptive anti-tumor agent |
| 01/02/2008 | EP1872797A2 Treatment of cardiovascular and related pathologies |
| 01/02/2008 | EP1872796A1 Transdermal preparation for external use containing nonsteroidal antiinflammatory/analgesic agent |
| 01/02/2008 | EP1872795A1 Therapeutic agent for irritable bowel syndrome |
| 01/02/2008 | EP1871409A2 Improved method and apparatus for treating bacterial infections in devices |
| 01/02/2008 | EP1871401A1 Use of lactobacillus rhamnosus gg for the treatment, prevention or reduction of systemic inflammation in a formula-fed infant |
| 01/02/2008 | EP1871372A1 Combination therapy comprising an n-type calcium channel blocker for the alleviation of pain |
| 01/02/2008 | EP1871371A2 Use of an epidermal growth factor receptor kinase inhibitor (egfr) in gefitinib resistant patients |
| 01/02/2008 | EP1631267B1 Method for treating diseases using hsp90-inhibiting agents in combination with antimetabolites |
| 01/02/2008 | EP1553962A4 Combination chemotherapy with chlorotoxin |
| 01/02/2008 | EP1550675B1 Phospholipid derivative |